MedPath

Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery

Not Applicable
Completed
Conditions
Aortic Valve Surgery
Postoperative; Pain
Interventions
Drug: Piritramid
Drug: Saline
Registration Number
NCT03079830
Lead Sponsor
University Medical Centre Ljubljana
Brief Summary

The study evaluates the efficacy of local anesthestic application through the catheter in the surgical wound for the postoperative pain relief after minimally invasive aortic valve surgery. The patients will be enrolled in two different groups according to the protocol of the local anesthetic and saline administration:

1. group: continous infusion of the local anesthetic plus bolus on demand

2. group: continous infusion of saline plus bolus on demand For all patients metamizol every 12 hours plus bolous of piritramid on demand.

Detailed Description

Patients undergoing minimally invasive aortic valve replacment surgery will be enroled in the study, after giving a signed informed consent.

The study evaluates the efficacy of local anesthestic application through the catheter in the surgical wound for the postoperative pain relief after minimally invasive aortic valve surgery.

Patients will then be randomised in two groups according to the protocol:

1. group: continous infusion of the local anesthetic plus bolus on demand

2. group: continous infusion of saline plus bolus on demand

All patients will receive Metamizol every 12 hours plus bolus of piritramid on demand.

Analgesia effectivness will be checked hourly according to the visual analogue scale (VAS). According to protocol, bolus will be given every time the score of VAS scale is \>3.

The catheter will be removed 48 hours after the protocols' start.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
  • Patients after minimally invasive aortic valve surgery
  • Patients agreement with the study
Exclusion Criteria
  • Age under 18 years
  • Allergy to local anesthetic

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Saline continousPiritramidPiritramid
Saline continousSalinePiritramid
Ropivacaine continous infusionPiritramidPiritramid
Primary Outcome Measures
NameTimeMethod
Comparison of cumulative postoperative dose of Piritramid between the two different protocols, using VAS scale to determine level of analgesia.48 hours after admission to the intensive care unit (ICU)

Comparison of cumulative postoperative dose of Piritramid between the two protocols

Secondary Outcome Measures
NameTimeMethod
Hospital lenght of stayUp to 30 days

Hospital lenght of stay

Patients satisfaction with pain relief measured by Likert-type Patient satisfaction scale72 hours after surgery

Patients satisfaction regarding pain relief, in the following order 1.very satisfied 2.satisfied 3.neither satisfied nor dissatisfied 4.dissatisfied 5.completely dissatisfied

Rate of complications related to the local anesthetic72 hours after surgery

Neurotoxicity and cardiotoxicity related to the local anesthetic

Complications related to the catheter in the surgical woundUp to 30 days

Complications related to the catheter in the surgical wound

Visual analogue scale (VAS), frequency of scores higher than 348 hours after admission to the ICU

Visual analogue scale (VAS), frequency of scores higher than 3

Trial Locations

Locations (1)

University Clinical Center Ljubljana

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath